Data Scientist, Covera Health
Casual Inference
$105-120k
+ Stock options + Discretionary bonus
Advanced clinical analytics
Open for applications
Advanced clinical analytics
21-100 employees
Open for applications
$105-120k
+ Stock options + Discretionary bonus
21-100 employees
Company mission
To aid healthcare providers and payers in a shared quest to better define, measure, and deliver the highest standard of care to patients everywhere.
Jump to section
Company mission
To aid healthcare providers and payers in a shared quest to better define, measure, and deliver the highest standard of care to patients everywhere.
Our take
Covera’s study of advanced imaging technology found complex diagnoses to have error rates of 30% or more. Their answer has been to develop powerful AI powered analytics tools to assist radiology providers in improving diagnostic accuracy, thereby reducing patient harm and healthcare expense.
It is a promising area in which to develop and deploy AI tools. Covera benefits from cloud-based access to medical records stretching back over a decade, and millions of associated data points, to refine and train their error recognition software.
Moreover, Covera is tapping into an expanding market. Not only do they serve providers in all 50 US states, they’re specializing in a niche area of a market that is expected to reach just over $80 billion by 2026. Healthcare analytics is expected to revolutionize the field over the next few years, and Covera is positioning itself as a strategically specialized player.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Cold Brew & Beer On Tap
- Unlimited Wellness Days
- Vision Insurance
- Discounted Citibike Membership
- High-Rise Offices with Lots of Light
- Fee-Free 401(k) Plan
- Medical Insurance
- Health Reimbursement Account
- Home, Office & In-Between
- Dental Insurance
- Paid Parental Leave
- Retirement & Development
- Home Office Stipend
- Pre-Tax Commuter Benefits
- Fully Stocked Kitchen & Snacks
- Annual Stipend for Personal Development
Funding (last 2 of 5 rounds)
Nov 2023
$25m
SERIES C
Aug 2021
$25m
SERIES C
Total funding: $86m
This company has top investors
Leadership
Ron Vianu
(CEO & Founder)After studying at New York University, Ron founded Park East Medical where he worked for 3 years, before serving as CEO of Transcion for 9 years. Having founded Spreemo Health in 2010, he used this experience to found Covera Health in September 2017, serving as CEO since.
Articles
Jobs (4)
Data
People, HR, Recruitment
Finance, Legal & Compliance